A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritisKristine L. Stump, Matthew M. Seavey|Arthritis Research & Therapy|2011Cited by 76
Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105Laurence M. Wood, Yvonne Paterson, Zhen-Kun Pan et al.|Cancer Immunology Immunotherapy|2011Cited by 69
Cancer immunotherapy using Listeria monocytogenes and listerial virulence factorsLaurence M. Wood, Yvonne Paterson, Patrick Guirnalda et al.|Immunologic Research|2008Cited by 62
The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapyLaurence M. Wood, Yvonne Paterson, Geetha Muthukumaran et al.|Cancer Immunology Immunotherapy|2011Cited by 54
Intracellular Facultative Bacterial Vectors for Cancer ImmunotherapyPatrick Guirnalda, Yvonne Paterson, Laurence M. Wood et al.|Unknown|2012Cited by 1